Literature DB >> 8606730

Chemotherapy for ovarian cancer.

E Cvitkovic, J L Misset.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8606730

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  Pharmacoeconomic considerations in treating ovarian cancer.

Authors:  D Bodurka-Bevers; C C Sun; D M Gershenson
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

Review 2.  Paclitaxel: a pharmacoeconomic review of its use in the treatment of ovarian cancer.

Authors:  M Young; G L Plosker
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

3.  Mechanisms of Cisplatin-Induced Apoptosis and of Cisplatin Sensitivity: Potential of BIN1 to Act as a Potent Predictor of Cisplatin Sensitivity in Gastric Cancer Treatment.

Authors:  Satoshi Tanida; Tsutomu Mizoshita; Keiji Ozeki; Hironobu Tsukamoto; Takeshi Kamiya; Hiromi Kataoka; Daitoku Sakamuro; Takashi Joh
Journal:  Int J Surg Oncol       Date:  2012-06-12

4.  SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response.

Authors:  Lei-Lei Chen; Huai-Peng Lin; Wen-Jie Zhou; Chen-Xi He; Zhi-Yong Zhang; Zhou-Li Cheng; Jun-Bin Song; Peng Liu; Xin-Yu Chen; Yu-Kun Xia; Xiu-Fei Chen; Ren-Qiang Sun; Jing-Ye Zhang; Yi-Ping Sun; Lei Song; Bing-Jie Liu; Rui-Kai Du; Chen Ding; Fei Lan; Sheng-Lin Huang; Feng Zhou; Suling Liu; Yue Xiong; Dan Ye; Kun-Liang Guan
Journal:  Cell Rep       Date:  2018-11-06       Impact factor: 9.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.